Hem › Spinal muskelatrofi › Illinois
Kliniska studier för Spinal muskelatrofi i Illinois
6 studier för Spinal muskelatrofi söker deltagare vid platser i Illinois.
Städer i Illinois
Officiell studietext (engelska)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- Ann and Robert H. Lurie Children Hospital of Chicago, Chicago
RekryterarFas 4
3 Months – 24 Months · Alla kön · Uppdaterad 2 okt. 2026 · NCT05861986A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 2
Ålder 5 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07287982A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1
Ålder 3 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Lurie Childrens Hospital, Chicago
Rekryterar
Ålder 3 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
RekryterarFas 3
0 Days – 42 Days · Alla kön · Uppdaterad 18 aug. 2026 · NCT07221669ALS/MND Natural History Study Data Repository
- Northwestern University, Chicago
RekryterarObservationsstudie
Ålder 18 till 90 · Alla kön · Uppdaterad 20 maj 2026 · NCT05966038Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.